25 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Loading...
Loading...

Gainers

  • T2 Biosystems, Inc. TTOO stock surged 30.1% to $1.86 during Wednesday's pre-market session. The market value of their outstanding shares is at $209.3 million. The most recent rating by Alliance Global Partners, on August 01, is at Neutral, with a price target of $0.40.
  • Lexicon Pharmaceuticals, Inc. LXRX stock surged 22.1% to $2.10. The market cap seems to be at $1.1 billion. The most recent rating by Citigroup, on July 30, is at Buy, with a price target of $3.00.
  • Outlook Therapeutics, Inc. OTLK stock surged 18.4% to $1.80. The market cap seems to be at $30.3 million.
  • Co-Diagnostics, Inc. CODX stock moved upwards by 10.5% to $1.16.
  • SINTX Technologies, Inc. SINT shares increased by 9.7% to $1.59. The market cap seems to be at $6.5 million.
  • Restoration Robotics, Inc. HAIR shares increased by 8.2% to $0.69. The market cap seems to be at $22.8 million.
  • vTv Therapeutics, Inc. VTVT stock moved upwards by 6.6% to $1.46.
  • Bellerophon Therapeutics, Inc. BLPH stock rose 5.8% to $0.55.
  • Catalyst Pharmaceuticals, Inc. CPRX shares moved upwards by 5.3% to $7.29. The market cap stands at $46.1 million.
  • Adaptimmune Therapeutics, Inc. ADAP stock moved upwards by 4.7% to $2.21. The market cap stands at $1.1 billion. According to the most recent rating by Guggenheim, on August 02, the current rating is at Neutral.
  • VBI Vaccines, Inc. VBIV shares increased by 4.5% to $0.65. The market value of their outstanding shares is at $59.9 million.
  • DelMar Pharmaceuticals, Inc. DMPI stock increased by 4.5% to $0.65. The most recent rating by Maxim Group, on September 06, is at Buy, with a price target of $2.00.
  • China SXT Pharmaceuticals, Inc. SXTC shares moved upwards by 4.3% to $2.40.
  • Precipio, Inc. PRPO shares increased by 3.7% to $2.54.
  • Xeris Pharmaceuticals, Inc. XERS shares rose 2.8% to $10.01. The market value of their outstanding shares is at $270.4 million. The most recent rating by Mizuho, on September 11, is at Buy, with a price target of $22.00.
  • Ra Medical Systems, Inc. RMED shares moved upwards by 2.4% to $1.71. The market cap stands at $34.9 million. The most recent rating by Piper Jaffray, on August 13, is at Neutral, with a price target of $1.50.
  • PolarityTE, Inc. PTE shares moved upwards by 2.2% to $4.70. The market value of their outstanding shares is at $143.1 million. The most recent rating by H.C. Wainwright, on July 08, is at Buy, with a price target of $8.00.
  • Adamis Pharmaceuticals, Inc. ADMP stock surged 2.0% to $0.80. The market cap stands at $66.0 million. According to the most recent rating by B. Riley FBR, on July 23, the current rating is at Neutral.

 

Losers

  • Mallinckrodt, Inc. MNK shares fell 6.7% to $3.63 during Wednesday's pre-market session. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
  • Endo International, Inc. ENDP shares declined 2.8% to $3.89. The market cap seems to be at $644.6 million. The most recent rating by Morgan Stanley, on July 15, is at Underweight, with a price target of $3.00.
  • Jaguar Health, Inc. JAGX shares plummeted 1.8% to $1.09. The market cap seems to be at $9.3 million.
  • Tilray, Inc. TLRY shares plummeted 1.8% to $30.58. According to the most recent rating by Ladenburg Thalmann, on July 17, the current rating is at Neutral.
  • Proteon Therapeutics, Inc. PRTO stock declined 1.4% to $0.36. The market value of their outstanding shares is at $26.8 million.
  • Clearside Biomedical, Inc. CLSD stock decreased by 1.4% to $0.73.
  • Alcon, Inc. ALC stock decreased by 1.0% to $59.59. The market value of their outstanding shares is at $28.1 billion. The most recent rating by Credit Suisse, on August 26, is at Outperform, with a price target of $73.00.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralBiotechnologyHealth CareHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...